"Lung adenocarcinoma"의 두 판 사이의 차이
| 3번째 줄: | 3번째 줄: | ||
*[[BAC]] ([[Bronchioloalveolar carcinoma]]) is a term which is no longer in use but was used between 2004 and 2011 to define a particular subtype of lung adenocarcinoma. | *[[BAC]] ([[Bronchioloalveolar carcinoma]]) is a term which is no longer in use but was used between 2004 and 2011 to define a particular subtype of lung adenocarcinoma. | ||
| − | **[[Adenocarcinoma in situ]], [[minimally invasive adenocarcinoma]] and [[invasive adenocarcinoma of the lung]] | + | **[[Adenocarcinoma in situ]], [[minimally invasive adenocarcinoma]] and [[invasive adenocarcinoma of the lung]](lepidic predominant adenocarcinoma (LPA), predominantly invasive adenocarcinoma with some nonmucinous lepidic component and invasive mucinous adenocarcinoma) 으로 재분류됨.<ref> https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209391/ </ref> |
2021년 3월 2일 (화) 13:55 판
Lung adenocarcinoma는 폐암의 한 종류이다.
- BAC (Bronchioloalveolar carcinoma) is a term which is no longer in use but was used between 2004 and 2011 to define a particular subtype of lung adenocarcinoma.
- Adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma of the lung(lepidic predominant adenocarcinoma (LPA), predominantly invasive adenocarcinoma with some nonmucinous lepidic component and invasive mucinous adenocarcinoma) 으로 재분류됨.[1]
- Adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma of the lung(lepidic predominant adenocarcinoma (LPA), predominantly invasive adenocarcinoma with some nonmucinous lepidic component and invasive mucinous adenocarcinoma) 으로 재분류됨.[1]